L00 Stock Overview
Operates in the cannabis industry. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Global Health Clinics Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.0005 |
| 52 Week High | CA$0.11 |
| 52 Week Low | CA$0.0005 |
| Beta | 1.92 |
| 11 Month Change | -92.31% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 33 Year Change | -99.89% |
| 5 Year Change | -99.96% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| L00 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -92.9% | 0.2% | 0.8% |
| 1Y | 0% | 13.9% | 8.6% |
Return vs Industry: L00 underperformed the German Healthcare industry which returned 17.4% over the past year.
Return vs Market: L00 underperformed the German Market which returned 9.1% over the past year.
Price Volatility
| L00 volatility | |
|---|---|
| L00 Average Weekly Movement | 1,766.6% |
| Healthcare Industry Average Movement | 4.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: L00's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: L00's weekly volatility has decreased from 3740% to 1767% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | n/a | Jay Dhaliwal | globalhealthltd.ca |
Global Health Clinics Ltd. operates in the cannabis industry. The company operates medical clinics, which guide patients through the process of becoming legal users of marijuana. It develops psilocybin products for research and usage for pharmaceutical purposes.
Global Health Clinics Ltd. Fundamentals Summary
| L00 fundamental statistics | |
|---|---|
| Market cap | €63.73k |
| Earnings (TTM) | -€709.34k |
| Revenue (TTM) | €58.60k |
1.1x
P/S Ratio-0.1x
P/E RatioIs L00 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| L00 income statement (TTM) | |
|---|---|
| Revenue | CA$86.36k |
| Cost of Revenue | CA$20.76k |
| Gross Profit | CA$65.60k |
| Other Expenses | CA$1.11m |
| Earnings | -CA$1.05m |
Last Reported Earnings
Apr 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.11 |
| Gross Margin | 75.96% |
| Net Profit Margin | -1,210.42% |
| Debt/Equity Ratio | -45.4% |
How did L00 perform over the long term?
See historical performance and comparison